Emmaus Life Sciences Valuation
| EMMADelisted Stock | USD 0.26 0.00 0.00% |
Emmaus Life seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Emmaus Life Sciences from reviewing the firm fundamentals such as Shares Outstanding of 49.56 M, shares owned by insiders of 38.73 %, and Operating Margin of (0.65) % as well as analyzing its technical indicators and probability of bankruptcy. . In general, most investors advise taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.
Overvalued
Today
Please note that Emmaus Life's price fluctuation is very steady at this time. Calculation of the real value of Emmaus Life Sciences is based on 3 months time horizon. Increasing Emmaus Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Emmaus otc stock is determined by what a typical buyer is willing to pay for full or partial control of Emmaus Life Sciences. Since Emmaus Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Emmaus OTC Stock. However, Emmaus Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.26 | Real 0.23 | Hype 0.26 | Naive 0.27 |
The real value of Emmaus OTC Stock, also known as its intrinsic value, is the underlying worth of Emmaus Life Sciences OTC Stock, which is reflected in its stock price. It is based on Emmaus Life's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Emmaus Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Emmaus Life Sciences helps investors to forecast how Emmaus otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Emmaus Life more accurately as focusing exclusively on Emmaus Life's fundamentals will not take into account other important factors: Emmaus Life Total Value Analysis
Emmaus Life Sciences is currently expected to have valuation of 49.41 M with market capitalization of 24.28 M, debt of 4.65 M, and cash on hands of 982 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Emmaus Life fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
49.41 M | 24.28 M | 4.65 M | 982 K |
Emmaus Life Investor Information
About 39.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.18. Emmaus Life Sciences last dividend was issued on the 18th of July 2019. The entity had 1:6 split on the 18th of July 2019. Based on the measurements of operating efficiency obtained from Emmaus Life's historical financial statements, Emmaus Life Sciences is not in a good financial situation at the present time. It has a very high chance of going through financial crunch in December.Emmaus Life Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Emmaus Life has an asset utilization ratio of 36.33 percent. This suggests that the OTC Stock is making $0.36 for each dollar of assets. An increasing asset utilization means that Emmaus Life Sciences is more efficient with each dollar of assets it utilizes for everyday operations.Emmaus Life Ownership Allocation
Emmaus Life holds a total of 49.56 Million outstanding shares. Emmaus Life Sciences retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Emmaus Life Profitability Analysis
The company reported the previous year's revenue of 20.61 M. Net Loss for the year was (15.95 M) with profit before overhead, payroll, taxes, and interest of 17.3 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Emmaus Life's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Emmaus Life and how it compares across the competition.
About Emmaus Life Valuation
The otc valuation mechanism determines Emmaus Life's current worth on a weekly basis. Our valuation model uses a comparative analysis of Emmaus Life. We calculate exposure to Emmaus Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Emmaus Life's related companies.Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California. Emmaus Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 58 people.
8 Steps to conduct Emmaus Life's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Emmaus Life's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Emmaus Life's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Emmaus Life's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Emmaus Life's revenue streams: Identify Emmaus Life's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Emmaus Life's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Emmaus Life's growth potential: Evaluate Emmaus Life's management, business model, and growth potential.
- Determine Emmaus Life's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Emmaus Life's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Emmaus Life Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 49.3 M | |
| Retained Earnings | -241.3 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Emmaus OTC Stock
If you are still planning to invest in Emmaus Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emmaus Life's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |